Clin Exp Otorhinolaryngol.  2011 Mar;4(1):11-17.

N-Acetylcysteine and N-Nitroarginine Methyl Ester Attenuate Carboplatin-Induced Ototoxicity in Dissociated Spiral Ganglion Neuron Cultures

Affiliations
  • 1Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. hongsh@skku.edu

Abstract


OBJECTIVES
Carboplatin, a platinum-containing anti-cancer drug used to treat a variety of cancers, induces ototoxicity. Since, reactive oxygen species (ROS) and nitric oxide (NO) seem to be responsible for this toxicity, the antioxidant, N-acetyl-L-cysteine (L-NAC), and NO synthetase inhibitor, N-nitro-L-arginine methyl ester (L-NAME) were predicted to have protective effects against carboplatin ototoxicity. The aim of this study was to test for the protective effects of L-NAC and L-NAME on cochlear hair cells and spiral ganglion neurons (SGNs).
METHODS
Cochlear organotypic cultures and dissociated spiral ganglion neuron cultures, from mice postnatal day 5 cultures were used in this study. The cultures were treated with carboplatin alone or in combination with L-NAC or L-NAME, and carboplatin-induced damage was monitored.
RESULTS
Treatment with carboplatin induced a significant loss of outer hair cells, while inner hair cells were preserved in the cochlear organotypic cultures. Addition of L-NAC or L-NAME reduced the amount of carboplatin-induced hair cell damage; the differences did not reach statistical significance. However, carboplatin significantly decreased the number of surviving SGNs in dissociated cultures. The toxic effects were significantly reduced by addition of L-NAC or L-NAME. In addition, carboplatin induced the loss of neurites from the SGN somata, and this was not blocked with L-NAC or L-NAME.
CONCLUSION
The results of this study suggest that ROS and NO are involved in carboplatin-induced damage to hair cells and SGNs, and administration of L-NAC/L-NAME can be used to attenuate the toxicity.

Keyword

Ototoxicity; Carboplatin; Nitric oxide; Spiral ganglion neuron; Inner hair cell; Outer hair cell; Mouse

MeSH Terms

Acetylcysteine
Animals
Carboplatin
Hair
Ligases
Lysine
Mice
Neurites
Neurons
NG-Nitroarginine Methyl Ester
Nitric Oxide
Reactive Oxygen Species
Spiral Ganglion
Acetylcysteine
Carboplatin
Ligases
Lysine
NG-Nitroarginine Methyl Ester
Nitric Oxide
Reactive Oxygen Species

Figure

  • Fig. 1 Confocal microscopic photomicrographs of cochlear organotypic cultures stained with FITC-conjugated phalloidin (green) and NF-200 (red). (A) Control showing a typical arrangement of three rows of outer hair cells, and single row of inner hair cells. (B) Cochlear cultures treated for 48 hours with carboplatin at a concentration of 100 mg/mL. (C) Cochlear cultures treated for 48 hours with 100 µg/mL carboplatin plus 100 µM N-nitro-L-arginine methyl ester. (D) Cochlear cultures treated for 48 hours with 100 µg/mL carboplatin plus 10 mM N-acetyl-L-cysteine. Scale bar represents 10 µm.

  • Fig. 2 Histogram shows mean number of outer hair cells (OHCs), per (A) and inner hair cells (IHCs) (B) per 0.2 mm length of the cochlea. Asterisk indicates that the carboplatin-treated group shows a statistically significant decrease in the OHC number compared to the control group. L-NAME: N-nitro-L-arginine methyl ester; L-NAC: N-acetyl-L-cysteine.

  • Fig. 3 Fluorescence microscopic photographs of dissociated spiral ganglion neuron cultures stained with NF-200 (green) and Hoechst (blue) after 72 hours of culture. (A) Untreated control, (B) 50 mg/mL carboplatin only, (C) 100 mM N-nitro-L-arginine methyl ester (L-NAME) only, (D) 100 mM N-acetyl-L-cysteine (L-NAC) only, (E) 50 mg/mL carboplatin+100 mM L-NAME, (F) 50 mg/mL carboplatin+100 mM L-NAC (×400).

  • Fig. 4 Histogram shows relative percentages of NF-200 positive cells (survived spiral ganglion neurons) in the dissociated spiral ganglion neuron (SGN) cultures for 72 hours. The survival of SGNs in each condition is shown as a relative percentage of survival to control (100%). The Wilcoxon rank sum test was used to compare the surviving SGNs in the conditioned culture groups with the control group. L-NAME: N-nitro-L-arginine methyl ester; L-NAC: N-acetyl-L-cysteine.


Reference

1. Ahmed SM, Cohen EE. Treatment of squamous cell carcinoma of the head and neck in the metastatic and refractory settings: advances in chemotherapy and the emergence of small molecule epidermal growth factor receptor kinase inhibitors. Curr Cancer Drug Targets. 2007; 11. 7(7):666–673. PMID: 18045071.
Article
2. Goffin J, Lacchetti C, Ellis PM, Ung YC, Evans WK. Lung Cancer Disease Site Group of Cancer Care Ontarios Program in Evidence-Based Care. First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review. J Thorac Oncol. 2010; 2. 5(2):260–274. PMID: 20101151.
Article
3. Marchetti C, Pisano C, Facchini G, Bruni GS, Magazzino FP, Losito S, et al. First-line treatment of advanced ovarian cancer: current research and perspectives. Expert Rev Anticancer Ther. 2010; 1. 10(1):47–60. PMID: 20014885.
Article
4. Esteban-Fernandez D, Verdaguer JM, Ramirez-Camacho R, Palacios MA, Gomez-Gomez MM. Accumulation, fractionation, and analysis of platinum in toxicologically affected tissues after cisplatin, oxaliplatin, and carboplatin administration. J Anal Toxicol. 2008; 3. 32(2):140–146. PMID: 18334097.
Article
5. Crepaldi de Almeida EO, Umeoka WG, Viera RC, de Moraes IF. High frequency audiometric study in cancer-cured patients treated with cisplatin. Braz J Otorhinolaryngol. 2008; May–Jun. 74(3):382–390. PMID: 18661012.
6. Dean JB, Hayashi SS, Albert CM, King AA, Karzon R, Hayashi RJ. Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens. J Pediatr Hematol Oncol. 2008; 2. 30(2):130–134. PMID: 18376265.
Article
7. Husain K, Whitworth C, Somani SM, Rybak LP. Carboplatin-induced oxidative stress in rat cochlea. Hear Res. 2001; 9. 159(1-2):14–22. PMID: 11520631.
Article
8. Kelly TC, Whitworth CA, Husain K, Rybak LP. Aminoguanidine reduces cisplatin ototoxicity. Hear Res. 2003; 12. 186(1-2):10–16. PMID: 14644455.
Article
9. Okur E, Kilinc M, Yildirim I, Kilic MA, Tolun FI. Effect of N-acetyl-cysteine on carboplatin-induced ototoxicity and nitric oxide levels in a rat model. Laryngoscope. 2007; 12. 117(12):2183–2186. PMID: 17909450.
10. Rahman Q, Abidi P, Afaq F, Schiffmann D, Mossman BT, Kamp DW, et al. Glutathione redox system in oxidative lung injury. Crit Rev Toxicol. 1999; 11. 29(6):543–568. PMID: 10628776.
Article
11. Coleman JK, Kopke RD, Liu J, Ge X, Harper EA, Jones GE, et al. Pharmacological rescue of noise induced hearing loss using N-acetylcysteine and acetyl-L-carnitine. Hear Res. 2007; 4. 226(1-2):104–113. PMID: 17023129.
Article
12. Shi X, Ren T, Nuttall AL. The electrochemical and fluorescence detection of nitric oxide in the cochlea and its increase following loud sound. Hear Res. 2002; 2. 164(1-2):49–58. PMID: 11950524.
Article
13. Diao M, Gao W, Sun J. Nitric oxide synthase inhibitor reduces noise-induced cochlear damage in guinea pigs. Acta Otolaryngol. 2007; 11. 127(11):1162–1167. PMID: 17851886.
Article
14. Hegarty JL, Kay AR, Green SH. Trophic support of cultured spiral ganglion neurons by depolarization exceeds and is additive with that by neurotrophins or cAMP and requires elevation of [Ca2+]i within a set range. J Neurosci. 1997; 3. 15. 17(6):1959–1970. PMID: 9045725.
15. Kushner BH, Budnick A, Kramer K, Modak S, Cheung NK. Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma. Cancer. 2006; 7. 15. 107(2):417–422. PMID: 16779793.
Article
16. Kim HJ, Lee JH, Kim SJ, Oh GS, Moon HD, Kwon KB, et al. Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity. J Neurosci. 2010; 3. 17. 30(11):3933–3946. PMID: 20237264.
Article
17. Lee JE, Nakagawa T, Kim TS, Endo T, Shiga A, Iguchi F, et al. Role of reactive radicals in degeneration of the auditory system of mice following cisplatin treatment. Acta Otolaryngol. 2004; 12. 124(10):1131–1135. PMID: 15768804.
Article
18. Li G, Liu W, Frenz D. Cisplatin ototoxicity to the rat inner ear: a role for HMG1 and iNOS. Neurotoxicology. 2006; 1. 27(1):22–30. PMID: 16125245.
19. Yamane H, Takayama M, Sunami K, Iguchi H, Kanazawa A, Tokuhara Y, et al. Nitric oxide induces apoptosis of the hair cells of cochlea. Acta Otolaryngol Suppl. 2004; 10. (554):6–11. PMID: 15513503.
Article
20. Watanabe K, Inai S, Jinnouchi K, Bada S, Hess A, Michel O, et al. Nuclear-factor kappa B (NF-kappa B)-inducible nitric oxide synthase (iNOS/NOS II) pathway damages the stria vascularis in cisplatin-treated mice. Anticancer Res. 2002; Nov–Dec. 22(6C):4081–4085. PMID: 12553036.
21. Takeno S, Wake M, Mount RJ, Harrison RV. Degeneration of spiral ganglion cells in the chinchilla after inner hair cell loss induced by carboplatin. Audiol Neurootol. 1998; Sep–Oct. 3(5):281–290. PMID: 9705525.
22. Jirsova K, Mandys V. Differences in the inhibition of neuritic outgrowth in organotypic cultures of rat foetal dorsal root ganglia treated with cisplatin and carboplatin: a comparative study. Folia Histochem Cytobiol. 1997; 35(4):215–219. PMID: 9619421.
23. Munnamalai V, Suter DM. Reactive oxygen species regulate F-actin dynamics in neuronal growth cones and neurite outgrowth. J Neurochem. 2009; 2. 108(3):644–661. PMID: 19054285.
Article
24. Evangelopoulos ME, Wüller S, Weis J, Krüttgen A. A role of nitric oxide in neurite outgrowth of neuroblastoma cells triggered by mevastatin or serum reduction. Neurosci Lett. 2010; 1. 01. 468(1):28–33. PMID: 19853642.
Article
25. Ohinata Y, Miller JM, Schacht J. Protection from noise-induced lipid peroxidation and hair cell loss in the cochlea. Brain Res. 2003; 3. 21. 966(2):265–273. PMID: 12618349.
Article
26. Ding DL, Wang J, Salvi R, Henderson D, Hu BH, McFadden SL, et al. Selective loss of inner hair cells and type-I ganglion neurons in carboplatin-treated chinchillas. Mechanisms of damage and protection. Ann N Y Acad Sci. 1999; 11. 28. 884:152–170. PMID: 10842592.
Article
27. Taudy M, Syka J, Popelár J, Ulehlová L. Carboplatin and cisplatin ototoxicity in guinea pigs. Audiology. 1992; 31(5):293–299. PMID: 1449432.
28. Wake M, Takeno S, Ibrahim D, Harrison R, Mount R. Carboplatin ototoxicity: an animal model. J Laryngol Otol. 1993; 7. 107(7):585–589. PMID: 15125271.
Article
29. Watanabe KC, Jinnouchi K, Hess A, Michel O, Baba S, Yagi T. Carboplatin induces less apoptosis in the cochlea of guinea pigs than cisplatin. Chemotherapy. 2002; 5. 48(2):82–87. PMID: 12011540.
Article
30. Saito T, Saito H, Saito K, Wakui S, Manabe Y, Tsuda G. Ototoxicity of carboplatin in guinea pigs. Auris Nasus Larynx. 1989; 16(1):13–21. PMID: 2475098.
Article
31. Kintzel PE. Anticancer drug-induced kidney disorders. Drug Saf. 2001; 1. 24(1):19–38. PMID: 11219485.
Article
Full Text Links
  • CEO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr